MJMichael A. Johnson

Michael A. Johnson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Michael A. Johnson has a total of 174 co-authors. Here are the top co-authors by number of shared publications:

  • Sam V. Kaplan

    Department of Chemistry and R.N. Adams Institute for Bioanalytical Chemistry, University of Kansas, Lawrence, Kansas 66045, United States

    6 shared publications
  • Andrea N. Ortiz

    Department of Chemistry and R. N. Adams Institute for Bioanalytical Chemistry, Lawrence, KS 66045 USA

    5 shared publications
  • Stephen C. Fowler

    Department of Pharmacology and Toxicology and Life Span Institute, Lawrence, KS 66045 USA

    5 shared publications
  • Timothy L. Macdonald

    B Department of Chemistry, University of Virginia, McCormick Road, Charlottesville, VA 22904, USA

    5 shared publications
  • Benjamin Gaston

    Departments of Pediatrics and Chemistry, University of Virginia, Charlottesville, VA 22904; and

    4 shared publications
  • Gregory L. Osterhaus

    University of Kansas

    4 shared publications

Latest Publications

  • Open Access

    Improved Serotonin Measurement With Fast‐Scan Cyclic Voltammetry: Analysis of Electrode Fouling by Fluoxetine in Live Brain Tissue

    by Chase Stucky, Delaney Lounce, Kailash Shrestha, Jing Tian, Ethan Gomez, Heng Du, Kandace Fleming, Michael A. Johnson

    Fast‐scan cyclic voltammetry at carbon‐fiber microelectrodes is a method of choice for measuring 5‐hydroxytryptamine (5‐HT, serotonin) in brain tissue. The classic Jackson–Nafion Waveform method (JNW) offers high sensitivity and selectivity over interferents like dopamine and fouling agents like 5‐hydroxyindoleacetic acid (5‐HIAA). Nevertheless, in vitro evidence suggests that JNW method is susceptible to fouling by radical oxidative serotonin products and selective serotonin reuptake inhibitors (SSRIs). This fouling was mitigated by using an extended serotonin waveform (ESW) on bare electrodes. To investigate these differences, further repeated, controlled spritzes of serotonin were conducted ex vivo in brain tissue from zebrafish and mice. The ESW resisted fouling better than the JNW after superfusion with 10 μM fluoxetine, with final normalized signals of 0.84 and 0.55, respectively. Furthermore, superfusion with 100 nM fluoxetine and physiologically relevant 5‐HIAA concentrations did not degrade electrode response when using either method. The electrochemical signal from serotonin release, evoked in the substantia nigra pars reticulata of mouse brain slices, was significantly greater after fluoxetine administration as measured with the ESW compared to the JNW. These results indicate that the ESW may be more suitable for ex vivo applications when used in combination with SSRIs.

  • Open Access

    Real‐Time Neurochemical Sensing in Zebrafish: Electrochemical and Fluorescent Approaches

    by Piyanka Hettiarachchi, Jacob T. Theismann, Michael A. Johnson

    Although originally used to study development, zebrafish ( Danio rerio ) have emerged as a model used to investigate neuronal function in health and disease. Zebrafish are advantageous for this purpose because they are easy to genetically manipulate, are economical to maintain, and share many evolutionarily conserved similarities with the mammalian central nervous systems. Importantly, ex vivo and in vivo preparations are amenable to analytical measurements that employ electrochemical and optical methods to measure fluctuations in neurotransmitter levels. In this review, we take a deeper look into how the inherent advantages of this model organism have been leveraged to unravel fundamental processes involved in neuronal function. To provide proper background and context, we first describe details on how zebrafish became a model for the study of development. We then provide an overview of zebrafish neuroanatomy, highlighting comparisons to mammals. Next, we discuss analytical methods that have been used to measure neurotransmitter and neuromodulatory levels in zebrafish. Finally, we examine specific applications of these methods used to measure real‐time changes in neurochemical levels. This review focuses on electrochemical and fluorescent sensing approaches for monitoring neurochemicals in viable zebrafish preparations, rather than providing a comprehensive examination of extracted‐tissue assays or clinical molecular imaging methods.

  • Open Access

    Analyses of dextroamphetamine and its metabolites in human urine by capillary electrophoresis with diode array and capacitively coupled contactless conductivity detection (CE-DAD-C4D)

    by L. A. A. Souza, S. M. Lunte, D. B. M. Weerasekara, M. A. Johnson, J. A. F. da Silva

    Dextroamphetamine is a psychostimulant widely used in the treatment of attention-deficit/hyperactivity disorder and as a model compound in clinical toxicology and pharmacokinetic studies, and some studies report its use in cocaine dependence treatment. The present work describes the development and validation of a capillary electrophoresis (CE) method coupled with diode array (DAD) and capacitively coupled contactless conductivity (C4D) detectors for the simultaneous analysis of dextroamphetamine and its main urinary metabolites. Although phenylacetone is a key intermediate in the oxidative deamination pathway, this study focuses on the determination of 4-hydroxyamphetamine, norephedrine, hippuric acid, and benzoic acid in synthetic urine and spiked human samples. The method was optimized for background electrolyte composition, pH, and separation voltage, allowing efficient resolution and dual detection. Rapid separations were obtained, with migration times under 8 min. Linear responses were observed for all compounds within 1-200 μM (R2 ≥ 0.955), with LOD/LOQ ranging 0.32-32.2 μM and 1.07-97.6 μM, respectively. For dextroamphetamine, migration occurred at 3.64 min (DAD) and 3.41 min (C4D), with LOD/LOQ of 2.16/7.19 μM (DAD) and 8.58/28.60 μM (C4D). Intra- and inter-day repeatability tests demonstrated analytical precision with acceptable limits. The method was applied to spiked human urine samples using the standard addition technique for endogenous metabolites (hippuric acid and benzoic acid). This study demonstrates the feasibility of clinical and toxicological monitoring involving psychostimulant determination.

  • Open Access

    Quantitative Control of Zn 2+ Photorelease: A Step toward Decoding Mechanisms of Subsecond Metal Signaling in the Brain

    by Sayuri Niyangoda, Jodie Kearney, Piyanka Hettiarachchi, Jacob Theismann, Austin Shigemoto, Erin E. Hickey, Shawn C. Burdette, Michael A. Johnson

    Free ionic zinc (Zn2+) exerts control over many aspects of neuronal function after its exocytotic release from vesicles by associating with conserved binding sites on regulatory proteins, including the dopamine transporter. While the use of photoreactive cages to investigate the influence of subsecond Zn2+ transients on neurotransmitter release and uptake is useful, a quantitative understanding of Zn2+'s regulatory effects requires knowing how much Zn2+ has been released. Here, we have addressed this issue by directly measuring 4-methoxy-3-nitrobenzaldehyde (3-NPA), a photoreaction byproduct from [Zn(DPAeCageOMe)]+, as a reporter to quantify Zn2+ photorelease. We optimized a sawhorse waveform, which eliminated fouling and provided a linear oxidation current response as concentration was increased. We then demonstrated the utility of our method by measuring released zinc ions evoked by light exposure in whole brains harvested from adult zebrafish ex vivo. Our findings revealed that zinc, which was released at concentrations of about 1 to 4 μM in response to light application durations of 300 to 900 ms, significantly increased dopamine overflow and inhibited dopamine uptake. The profound effects of low concentrations of Zn2+ on release and uptake raise the possibility that Zn2+, which is released from terminals at concentrations of 10 to 20 μM, acts as a volume neuromodulator, with targets beyond respective postsynaptic terminals. Given that Zn2+ dysregulation is a well-established phenomenon in Parkinson's and Alzheimer's diseases, application of our newly developed method may provide insight into these disorders.


  • Zinc-Dependent Modulation of Dopamine Release and Uptake Is Altered in Parkinson’s Disease Model Zebrafish

    by Piyanka Hettiarachchi, Austin Shigemoto, Erin E. Hickey, Shawn C. Burdette, Michael A. Johnson

    Parkinson's disease (PD) is a neurodegenerative movement disorder in which dopaminergic neurons progressively degenerate, resulting in impaired dopamine system function. The release and uptake of dopamine (DA) are modulated, in part, by free, ionic zinc (Zn2+), an essential signaling metal. Although alterations in Zn2+ homeostasis are implicated in PD, the influence of Zn2+ on DA release and uptake that occurs within the subsecond time frame has not been studied in PD, or other disorders. In this study, we combined caged-compound photolysis with fast-scan cyclic voltammetry (FSCV) at carbon-fiber microelectrodes to investigate the impact of Zn2+ photorelease on DA release and reuptake in PD-model zebrafish, generated by chronic treatment with rotenone, and vehicle-treated control fish. Our findings reveal that Zn2+ photorelease inhibited peak DA overflow by about 20% in brains from PD model fish but not in those from vehicle-treated fish. Further analysis of the stimulated release plots showed a significant decrease in the first order rate constant of uptake (k) and an increase in the half-life (t1/2) in brains from vehicle-treated fish but not in those from PD model fish. These differences were not apparent when waiting more than 200 ms to electrically stimulate the brain after the end of light application. Treatment with the free-radical scavenger TEMPOL reversed the effect of Zn2+ photorelease on DA release but not on DA uptake. Thus, oxidative stress likely plays a key role, acting reversibly on DA release and irreversibly on DA uptake. In summary, our study demonstrates the feasibility of our approach in elucidating the mechanisms underlying the effects of metal ions on Parkinson's disease.


  • Doxorubicin treatment has a biphasic effect over time on dopamine release and impulsive behavior in Wistar rats

    by Kiersten J. Garcia, Jacob T. Theismann, Tadd D. Schneider, Robert S. LeComte, David P. Jarmolowicz, Michael A. Johnson

    Doxorubicin (Dox) is a chemotherapy agent commonly used to treat multiple types of cancers and is associated with cognitive impairment. The goal of this work was to determine the effect of Dox treatment on dopamine release and uptake and behavior in rats. Rats received one dose per week of Dox (2.5 mg/kg, I.V.) and were sacrificed after two or four weeks. Dopamine release and uptake was measured in brain slices with fast-scan cyclic voltammetry (FSCV). A set of rats that received treatment also underwent behavioral testing with the 5-choice serial reaction timed task (5CSRTT) to measure degree of impulsiveness and attention throughout the course of treatment. Dopamine release and uptake increased substantially after treatment with Dox for two weeks compared to controls. After four weeks of treatment, release levels decreased to less than controls while there were no differences in uptake. Treatment of brain slices with pramipexole revealed that dopamine release was equally sensitive to autoregulation after two weeks of Dox treatment, but less sensitive after four weeks. Measurements from the 5CSRTT indicated that, while Dox did not affect attention, it increased impulsiveness after two and three weeks of treatment, but not after four weeks. Treatment with Dox for a short time may elevate dopamine system activity and increase impulsiveness, while longer administration then leads to an underactive dopamine system. To our knowledge this work demonstrates for the first time that Dox can have a biphasic neurochemical and behavioral effect.


  • Pair bond quality influences social conditioned place preference expression, passive coping behavior, and central oxytocin receptor expression following partner loss in male prairie voles

    by Erika M. Vitale, Amina H. Tbaba, Sophia Sanchez, Luanne Hale, William M. Kenkel, Michael A. Johnson, Adam S. Smith

    The dissolving of social bonds is disruptive and leads to increased stress responsivity and a strong desire for reunion. The oxytocin (OXT) system is critical for the formation of social attachments, such as pair bonds, and is also involved in social recognition, social memory, and social vigilance. Therefore, long-term changes in the OXT system resulting from cohabitation and pair bonding may contribute to reunion-seeking behavior. Here, we employed social conditioned place preference (SCPP) and the forced swim test (FST) to examine sensitivity to partner-associated contexts and passive stress coping following a period of partner separation. We found that opposite-sex cohabitation led to SCPP formation only in male prairie voles with a strong preference for their partner, and this SCPP was maintained following short-term loss of a pair bonded partner. Furthermore, pair bonded males that were separated from their partner displayed more passive stress-coping than those that were not bonded to their lost partner, suggesting that differences in prairie vole mating tactics (i.e. formation of a bond or not) influence the behavioral response to partner separation. Finally, we found changes in OXTR binding that may reflect variation in loss-related behavioral phenotypes based on different mating strategies.


  • Caged Zn2+ Photolysis in Zebrafish Whole Brains Reveals Subsecond Modulation of Dopamine Uptake

    by Piyanka Hettiarachchi, Sayuri Niyangoda, Austin Shigemoto, Isabel J. Solowiej, Shawn C. Burdette, Michael A. Johnson

    Free, ionic zinc (Zn2+) modulates neurotransmitter dynamics in the brain. However, the sub-s effects of transient concentration changes of Zn2+ on neurotransmitter release and uptake are not well understood. To address this lack of knowledge, we have combined the photolysis of the novel caged Zn2+ compound [Zn(DPAdeCageOMe)]+ with fast scan cyclic voltammetry (FSCV) at carbon fiber microelectrodes in live, whole brain preparations from zebrafish (Danio rerio). After treating the brain with [Zn(DPAdeCageOMe)]+, Zn2+ was released by application of light that was gated through a computer-controlled shutter synchronized with the FSCV measurements and delivered through a 1 mm fiber optic cable. We systematically optimized the photocage concentration and light application parameters, including the total duration and light-to-electrical stimulation delay time. While sub-s Zn2+ application with this method inhibited DA reuptake, assessed by the first-order rate constant (k) and half-life (t1/2), it had no effect on the electrically stimulated DA overflow ([DA]STIM). Increasing the photocage concentration and light duration progressively inhibited uptake, with maximal effects occurring at 100 μM and 800 ms, respectively. Furthermore, uptake was inhibited 200 ms after Zn2+ photorelease, but no measurable effect occurred after 800 ms. We expect that application of this method to the zebrafish whole brain and other preparations will help expand the current knowledge of how Zn2+ affects neurotransmitter release/uptake in select neurological disease states.


  • Mitochondrial Dysfunction Links to Impaired Hippocampal Serotonin Release in a Mouse Model of Alzheimer’s Disease

    by Jing Tian, Chase Samuel Stucky, Tienju Wang, Nancy A. Muma, Michael Johnson, Heng Du

    Background: Deprivation of extracellular serotonin has been linked to cognitive decline and neuropsychiatric disturbances in Alzheimer’s disease (AD). However, despite degeneration of serotonin-producing neurons, whether serotonin release is affected in AD-sensitive brain regions is unknown. Objective: This study investigated the impact of mitochondrial dysfunction in decreased hippocampal serotonin release in AD amyloidosis mouse model 5xFAD mice. Methods: Electrochemical assays were applied to examine hippocampal serotonin release. We also employed multidisciplinary techniques to determine the role of oligomeric amyloid-β (Aβ) in hippocampal mitochondrial deficits and serotonin release deficiency. Results: 5xFAD mice exhibited serotonin release decrease and relatively moderate downregulation of serotonergic fiber density as well as serotonin content in the hippocampal region. Further experiments showed an inhibitory effect of oligomeric amyloid-β (Aβ) on hippocampal serotonin release without affecting the density of serotonergic fibers. Pharmaceutical uncoupling of mitochondrial oxidative phosphorylation (OXPHOS) disrupted hippocampal serotonin release in an ex vivo setting. This echoes the mitochondrial defects in serotonergic fibers in 5xFAD mice and oligomeric Aβ-challenged primary serotonergic neuron cultures and implicates a link between mitochondrial dysfunction and serotonin transmission defects in AD-relevant pathological settings. Conclusion: The most parsimonious interpretation of our findings is that mitochondrial dysfunction is a phenotypic change of serotonergic neurons, which potentially plays a role in the development of serotonergic failure in AD-related conditions.


  • Open Access

    Spatiotemporal Imaging of Zinc Ions in Zebrafish Live Brain Tissue Enabled by Fluorescent Bionanoprobes

    by Romana Jarosova, Sarah K. Woolfolk, Noraida Martinez-Rivera, Mathew W. Jaeschke, Eduardo Rosa-Molinar, Candan Tamerler, Michael A. Johnson

    The zebrafish is a powerful model organism to study the mechanisms governing transition metal ions within whole brain tissue. Zinc is one of the most abundant metal ions in the brain, playing a critical pathophysiological role in neurodegenerative diseases. The homeostasis of free, ionic zinc (Zn2+) is a key intersection point in many of these diseases, including Alzheimer’s disease and Parkinson’s disease. A Zn2+ imbalance can eventuate several disturbances that may lead to the development of neurodegenerative changes. Therefore, compact, reliable approaches that allow the optical detection of Zn2+ across the whole brain would contribute to our current understanding of the mechanisms that underlie neurological disease pathology. We developed an engineered fluorescence protein-based nanoprobe that can spatially and temporally resolve Zn2+ in living zebrafish brain tissue. The self-assembled engineered fluorescence protein on gold nanoparticles was shown to be confined to defined locations within the brain tissue, enabling site specific studies, compared to fluorescent protein-based molecular tools, which diffuse throughout the brain tissue. Two-photon excitation microscopy confirmed the physical and photometrical stability of these nanoprobes in living zebrafish (Danio rerio) brain tissue, while the addition of Zn2+ quenched the nanoprobe fluorescence. Combining orthogonal sensing methods with our engineered nanoprobes will enable the study of imbalances in homeostatic Zn2+ regulation. The proposed bionanoprobe system offers a versatile platform to couple metal ion specific linkers and contribute to the understanding of neurological diseases.